Nasal vaccine against whooping cough

submitted by: COMED2010
Despite large coverage with efficacious vaccines, whooping cough is still a major cause of global childhood morbidity and mortality. In an effort to solve this problem, the Child-Innovac programme has developed a new vaccine designed to be given as a single dose at birth in order to protect young children, under 6 months of age, which is the most vulnerable age group and not sufficiently protected by the current vaccines. The new vaccine is based on a novel concept of nasal administration of...

Personalized Medicine Symposium at SfN

submitted by: brainresource

Symposium on:
Brain-related Personalized Medecine
Held at Society for Neuroscience, 2007